Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: "I think part of the explanation ..." It has to do with the REALITY of the

situation. A win at the ITC would have positively impacted the MMP because it would have given us that singularly most important element over the infringers; LEVERAGE. The infringers strategy of drawing out discussions through the court system or negotiations would have been turned on it's head, and TIME would have then become THEIR enemy. That didn't happen. So ...

Licensing is stalled.

The BK court will likely find for DL on some of his side's issues.

Any potential remaining relationship with Alliasence or Court mandated orders to TPL will be problematic and full of slow play going forward.

There are only 18 months left on the MMP's Patent protection, and no plan has been suggested, addressed or announced where shareholder's can have any confidence of mass prosecutions or sufficient licensings that will positively impact our share price potential enough for new buyers to want to acquire shares.

The NDOC HTC award and other licence revelations from that trial do not support large dollar damages going forward.

The leadership of PTSC is not trusted, and in my view is not even capable of increasing Shareholder value.

It's an ugly risky mess that is completely out of PTSC's own control. The only reason more folks aren't selling is that they have already suffered this long and this deep, and they hold hope that there is an outside chance that some event will occur at some point which will positively impact the stock price back to 22+ cents.

PTSC stock is not longer an "investment", it's become a 100% gamble.

Share
New Message
Please login to post a reply